Pregnancy Clinical Trial
Official title:
Evaluation of the Effectiveness of Transcutaneous Electrical Nerve Stimulation During Labor. A Triple Blind Randomized Clinical Trial
This study evaluates the effectiveness of the Transcutaneus Electric Nerve Stimulation (TENS)
during the labour. TENS is a low frequency electrotherapy technique, analgesic type,
generally used in musculoskeletal pathology.
The investigators will have three groups of participants to be administered the TENS, a
different dose in two groups, while the third will correspond to placebo.
The hypothesis of the study is to verify if the TENS is effective as a non-pharmacological
method in the relief of pain during childbirth
1. Background:
Pain during labour is one of the most intense pain that many women could experience
during their lives, and it can be influenced by the anatomical and physiological factors
of the labouring women, and also, by their psychological experiences, as well as by
cultural, social, and environmental factors.
Neuraxial analgesia during labour is the most effective method for pain relief, but it
appears to be associated with certain side effects, such as maternal hypotension,
decreased uteroplacental perfusion, foetal bradycardia, fever, pruritus, an increased
oxytocin requirement, a prolonged second stage of labour, a higher rate of operative
delivery, and high costs.
The use of non-pharmacological methods for pain relief includes a wide variety of
techniques aimed at improving physical sensations and preventing psychoemotional
perception of pain. Among the main nonpharmacological methods of pain relief at delivery
is the application of Transcutaneous electrical nerve stimulation (TENS). Its
application during childbirth is based on the Gait Control theory of pain of Melzack and
Wall. According to their theory, the application of TENS reduces the excitability of the
delta A and C pain fibers, thus reducing the amount of painful messages ascending the
spinal cord. Activation of these fibers stimulates the release of natural pain
inhibitors.
Furthermore, many non-pharmacological methods of managing pain increase the satisfaction
of women with their childbirth experience.
TENS have used for labour analgesia and there are several studies which show its
effectiveness. The effectiveness of TENS depends on the duration, frequency and
amplitude of the stimulating current and the site of application of the electrodes. TENS
can be administered by either dermatomal stimulation or by stimulation of acupuncture
points for labour analgesia. In addition, all studies stated that it was safe and there
was no side effects on the mother and the baby.
This work was conducted to study the effectiveness of TENS on labour analgesia, maternal
and fetal outcome using TENS by dermatomal stimulation technique. Thus, device will be
used as follows:
Through electrodes applied to the lower back, the parturient can control both
parameters, the frequency and intensity of the low-voltage electrical impulses emitted
from the TENS device. When applying to the lower back, the TENS unit emits electrical
impulses which excite afferent nerves, and thus inhibit the transmission of painful
stimuli arising from the uterus, vagina and perineum during labour. These electrodes are
attached to the skin bilaterally at paravertebral positions T10 and S2.
In the present study the investigators will use three equal devices (two different dose
and one placebo) .They will be assigned a number that associate to each group of
participants.
Safety profile in the use of TENS:
It is a non-invasive technique, easy to administer, without side effects or interactions
with other drugs, it cannot produce toxicity in the tissue or cellular level.
The current literature does not reflect any complications, either on the part of the
pregnant woman and in the fetus, during the application of TENS in the labor phase.
The use of TENS should be contraindicated in women whose gestational age does not exceed
37 weeks, women with pacemakers and water births. It should not be applied in the
maternal abdomen, at any time during pregnancy or childbirth, to avoid stimulation near
the fetal heart.
2. Objectives:
Primary aim:
- To know if the application of TENS is effective in reducing pain during childbirth.
Secondary aim:
- To determine the most effective dose in the use of TENS in pregnant women during
labor.
- To analyze the degree of satisfaction of the pregnant women who participate in the
study.
- To evaluate whether the use of TENS reduces the dose of the painkillers during
childbirth.
3. Material and Methods:
This study is a triple blind randomized trial with concealed allocation, assessor blinding
for some outcomes, and intention-to-treat analysis.
It was accepted by the Ethic Committee of the Hospital Complejo Hospitalario Universitario
Insular Materno Infantil of Las Palmas de Gran Canaria, Canary Islands, Spain, with
registration number CEIm-CHUIMI-2016/875.
3.1. Allocation: All participants will be recruited from a group of women admitted to the
hospital. If the pregnant woman meets the inclusion criteria, she will be asked to
participate in the study. If yes, they must sign the informed consent, approved by the same
ethical committee of the hospital.
The assignment to each group was made through the website www.random.org to perform
randomization. In addition, each group has a different TENS, which has the group number.
Participants in all groups will receive all the other routine obstetric care.
3.2. Sample size determination: The sample size and power calculations were performed using
the software GRANMO 7.11. Calculations were based on detecting differences of 2 units in a 10
numerical pain rate scale at post-data, assuming a standard deviation of 1.9, a 2-tailed
test, an alpha level of 0.05, and a desired power of 80%. These assumptions generated a
sample size of 63 subjects, 21 per group.
There is a specialiced nurse that will supervised the correct functionality every day. He
will be responsible for resolving dispositive problems like low charge or insufficient
electrodes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |